null
ChEBI ID: 38188
| Member | Definition | Role |
|---|---|---|
| 2-(4-(dimethylamino)styryl)-1-methylpyridinium | 2-[4-(dimethylamino)styryl]-1-methylpyridinium iodide | |
| 4-(4-diethylaminostyryl)-n-methylpyridinium | An organic iodide salt consisting of pyridinium iodide having a methyl substituent at the 1-position and a 4-diethylaminostyryl substituent at the 4-position. | 4-(4-diethylaminostyryl)-1-methylpyridinium iodide |
| fm1 43 | FM 1-43 dye | |
| GS4012 | A hydrochloride obtained by combining the free base of GS4012 with one molar equivalent of hydrochloric acid. | GS4012 |
| pralidoxime chloride | pralidoxime chloride | |
| pralidoxime iodide | An organic iodide salt that has pralidoxime as the cation. | pralidoxime iodide |
| pralidoxime iodide | An organic iodide salt that has pralidoxime as the cation. | pralidoxime iodide |
| pyridostigmine bromide | Pyridostigmine bromide | |
| sterogenol | A pyridinium salt that has N-hexadecylpyridinium as the cation and bromide as the anion. | cetylpyridinium bromide |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 486 (21.69) | 18.7374 |
| 1990's | 552 (24.63) | 18.2507 |
| 2000's | 610 (27.22) | 29.6817 |
| 2010's | 461 (20.57) | 24.3611 |
| 2020's | 132 (5.89) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 179 (7.46%) | 5.53% |
| Reviews | 112 (4.67%) | 6.00% |
| Case Studies | 381 (15.88%) | 4.05% |
| Observational | 5 (0.21%) | 0.25% |
| Other | 1,723 (71.79%) | 84.16% |